AI-generated summary
The authors randomized 81 people with depression to morning or evening bright light therapy or placebo light for two weeks and measured anhedonia, melatonin, cortisol and depressive symptoms. They report that morning bright light therapy improved anhedonia scores compared with morning placebo, and that this change was associated with a delayed melatonin peak. Depressive symptoms improved after both morning and evening bright light therapy.
- Participants
- 81
- Who or what was studied
- Patients with depression
- Limits stated in the abstract
- The abstract does not state the wavelength of the light used, and the associations reported are correlational rather than evidence of causation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Randomized controlled trial, Placebo-controlled, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.